EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Novel application of chelator-based bone debridement for refractory skull osteonecrosis complicated by Pseudomonas aeruginosa osteomyelitis

Minghsun Liu iD, Holly Prentice, Steven Cheng-Han Tsai

Journal of Wound Care · 2025

DOI: 10.12968/jowc.2024.0348 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Wound Care, 2025. Verfasst von Minghsun Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: MD, PhD, Woundtech, Hollywood, Florida & Los Angeles, California, US. Hauptthemen laut MEDLINE: Debridement, Osteomyelitis, Pseudomonas Infections, Pseudomonas aeruginosa. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This case report details the treatment of a 58-year-old male patient with a complex medical history, including renal transplants, immunosuppression and anticoagulation therapy. The patient developed skull osteonecrosis complicated by Pseudomonas aeruginosa osteomyelitis following treatment for squamous cell carcinoma of the scalp. After multiple failed reconstructive surgeries and advanced wound care attempts, an innovative chelator-based bone debridement strategy was implemented as part of an advanced wound care plan at home. This approach led to >50% reduction in the area of bone exposure and eliminated Pseudomonas aeruginosa from bone cultures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DebridementOsteomyelitisPseudomonas InfectionsPseudomonas aeruginosaOsteonecrosisSkullChelating AgentsHumansMaleMiddle Aged

Stichwörter der Autor:innen

Pseudomonas aeruginosa osteomyelitisRC Prep gelchelator-based bone debridementreconstructive surgery failureskull osteonecrosissquamous cell carcinomawoundwound carewound dressingwound healing

Substanzen

Chelating Agents

Autor:innen und Institutionen

  • MD, PhD, Woundtech, Hollywood, Florida & Los Angeles, California, US.
  • PA-C, Infectious Diseases, PrimeWest/Centinela Hospital Medical Center IM Residency Program, Inglewood, California, US.
  • MD, California University of Science and Medicine, Colton, California, US.

ORCID-Profile: Minghsun Liu

Förderung

  • NIAID NIH HHS

Zitieren

APA

Liu, M., Prentice, H., & Tsai, S. C. (2025). Novel application of chelator-based bone debridement for refractory skull osteonecrosis complicated by Pseudomonas aeruginosa osteomyelitis. Journal of Wound Care. https://doi.org/10.12968/jowc.2024.0348

Vancouver

Liu M, Prentice H, Tsai SC. Novel application of chelator-based bone debridement for refractory skull osteonecrosis complicated by Pseudomonas aeruginosa osteomyelitis. Journal of Wound Care. 2025. doi:10.12968/jowc.2024.0348

BibTeX
@article{Liu2025,
  author = {Liu, Minghsun and Prentice, Holly and Tsai, Steven Cheng-Han},
  title = {Novel application of chelator-based bone debridement for refractory skull osteonecrosis complicated by Pseudomonas aeruginosa osteomyelitis},
  journal = {Journal of Wound Care},
  year = {2025},
  doi = {10.12968/jowc.2024.0348}
}
Kostenlos starten →